๐ฌIn plain words
What the trial is, and whether it could suit you
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Sign in to get the eligibility rules as simple questions to take to your doctor.
๐ Eligibility rules (as published)
Inclusion Criteria:
* designated female at birth
* 40-60 years of age
* able to give informed consent (no intellectual disability)
* stable pharmacotherapeutic regimen, no change in the past 3 months
* abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use for 3 months
* abstinent for supplements, don't add any supplements (no changes in past 3 months)
* own a smartphone
* have access to Zoom on a secure, stable internet connection
* perimenopausal or menopausal
Exclusion Criteria:
* currently taking anti-depressant, anti-anxiety, and/or antipsychotic medication
* severe depression, neurovegetative symptoms, or current suicidality
* psychosis or family history of psychosis
* pregnant or breastfeeding
* chemotherapy
* hypotension
* drug testing for work or other reasons
* illicit drug use in past 3 months (cannabis not illicit)
* heavy alcohol use (4 drinks more than 4x/week)
* international/air travel planned for more than one week in the next 3 months
* cocounut allergy
๐
What it tests
- Hemp-derived cannabinoids
- Placebo
Washington State University, Dept of Psychology
Pullman, United States
๐ค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ always decide together with your own doctor.